Charles Schwab To Replace Biogen In S&P 100
(RTTNews) - S&P 500 constituent The Charles Schwab Corp. (SCHW) will replace Biogen Inc. (BIIB) in the S&P 100 effective prior to the opening of trading on March 21, Standard & Poor's said in a statement.
Biogen will remain in the S&P 500.
BellRing Brands Inc. (BRBR) will replace Cerence Inc. (CRNC) in the S&P MidCap 400, and Cerence will replace Cooper-Standard Holdings Inc. (CPS) in the S&P SmallCap 600 effective prior to the opening of trading on March 14.
S&P MidCap 400 constituent Post Holdings Inc. (POST) is converting its interest in BellRing Brands into new BellRing Brands stock and then distributing 80.1% of that interest to shareholders on March 11.
Following the distribution, Post Holdings will remain in the S&P MidCap 400.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.